1,168
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Multicenter phase IV study of palonosetron in the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with non-Hodgkin lymphomas undergoing repeated cycles of moderately emetogenic chemotherapy

, , , &
Pages 544-550 | Received 25 Feb 2013, Accepted 05 Jun 2013, Published online: 24 Jul 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Bernardo Rapoport, Ronwyn van Eeden & Teresa Smit. (2017) Rolapitant for the prevention of delayed nausea and vomiting over initial and repeat courses of emetogenic chemotherapy. Expert Review of Clinical Pharmacology 10:1, pages 17-29.
Read now
Michelle Zhou, Marko Popovic, Mark Pasetka, Natalie Pulenzas, Soha Ahrari, Edward Chow & Carlo DeAngelis. (2015) Update on the management of chemotherapy-induced nausea and vomiting – focus on palonosetron. Therapeutics and Clinical Risk Management 11, pages 713-729.
Read now

Articles from other publishers (12)

Yu. E. Ryabukhina, P. A. Zeynalova, O. L. Timofeeva & F. M. Abbasbeyli. (2022) Prevention of induced nausea and vomiting in patients with malignant blood disorders. Experience of using netupitant/palonosetron (Akynzeo). MD-Onco 2:4, pages 71-77.
Crossref
Nicola Di Renzo, Maurizio Musso, Rosanna Scimè, Alessandra Cupri, Tommasina Perrone, Clara De Risi, Domenico Pastore, Attilio Guarini, Andrea Mengarelli, Fabio Benedetti, Patrizio Mazza, Saveria Capria, Patrizia Chiusolo, Luca Cupelli, Vincenzo Federico, Valentina Bozzoli, Anna Rita Messa, Rosella Matera, Davide Seripa, Paolo Codega, Erminio Bonizzoni & Giorgina Specchia. (2021) Efficacy and safety of netupitant/palonosetron combination (NEPA) in preventing nausea and vomiting in non-Hodgkin’s lymphoma patients undergoing to chemomobilization before autologous stem cell transplantation. Supportive Care in Cancer 30:2, pages 1521-1527.
Crossref
Celina de Jesus Guimarães, Sarah Sant’ Anna Maranhão, Pedro Mikael da Silva Costa & Claudia Pessoa. 2021. Chemotherapy and Pharmacology for Leukemia in Pregnancy. Chemotherapy and Pharmacology for Leukemia in Pregnancy 145 179 .
Nicola Di Renzo, Maurizio Musso, Rosanna Scimè, Alessandra Cupri, Tommasina Perrone, Clara De Risi, Domenico Pastore, Attilio Guarini, Andrea Mengarelli, Fabio Benedetti, Patrizio Mazza, Vera Capria, Patrizia Chiusolo, Luca Cupelli, Vincenzo Federico, Valentina Bozzoli, Anna Rita Messa, Paolo Codega, Erminio Bonizzoni & Giorgina Specchia. (2020) Efficacy and safety of multiple doses of NEPA without dexamethasone in preventing nausea and vomiting induced by multiple-day and high-dose chemotherapy in patients with non-Hodgkin’s lymphoma undergoing autologous hematopoietic stem cell transplantation: a phase IIa, multicenter study. Bone Marrow Transplantation 55:11, pages 2114-2120.
Crossref
Meinolf Karthaus, Daniel Voisin, Giada Rizzi & Tudor Ciuleanu. (2020) Phase 3 Study of Palonosetron IV Infusion Vs. IV Bolus for Chemotherapy-Induced Nausea and Vomiting Prophylaxis After Highly Emetogenic Chemotherapy. Journal of Pain and Symptom Management 60:3, pages 568-576.
Crossref
Tsutomu Takahashi, Takahiro Okada, Fumiyoshi Ikejiri, Shunsuke Ito, Yusuke Okada, Fumimasa Takahashi, Satoshi Kumanomido, Yumi Jo, Koji Adachi, Chie Onishi, Koshi Kawakami, Takaaki Miyake, Masaya Inoue, Ritsuro Suzuki & Junji Suzumiya. (2017) A prospective study of palonosetron for prevention of chemotherapy-induced nausea and vomiting in malignant lymphoma patients following highly emetogenic chemotherapy. International Journal of Clinical Oncology 23:1, pages 189-194.
Crossref
Bungo Saito, Hidetoshi Nakashima, Maasa Abe, So Murai, Yuta Baba, Nana Arai, Yukiko Kawaguchi, Shun Fujiwara, Nobuyuki Kabasawa, Hiroyuki Tsukamoto, Yui Uto, Hirotsugu Ariizumi, Kouji Yanagisawa, Norimichi Hattori, Hiroshi Harada & Tsuyoshi Nakamaki. (2017) Efficacy of palonosetron to prevent delayed nausea and vomiting in non-Hodgkin’s lymphoma patients undergoing repeated cycles of the CHOP regimen. Supportive Care in Cancer 26:1, pages 269-274.
Crossref
Mayako Uchida, Yasuo Mori, Tsutomu Nakamura, Koji Kato, Kenjiro Kamezaki, Katsuto Takenaka, Motoaki Shiratsuchi, Kaori Kadoyama, Toshihiro Miyamoto & Koichi Akashi. (2017) Comparison between Antiemetic Effects of Palonosetron and Granisetron on Chemotherapy-Induced Nausea and Vomiting in Japanese Patients Treated with R-CHOP. Biological & Pharmaceutical Bulletin Biological and Pharmaceutical Bulletin 40:9, pages 1499-1505.
Crossref
Yoshiharu Miyata, Kimikazu Yakushijin, Yumiko Inui, Yoshinori Imamura, Hideaki Goto, Yu Mizutani, Keiji Kurata, Seiji Kakiuchi, Yukinari Sanada, Yosuke Minami, Shinichiro Kawamoto, Katsuya Yamamoto, Mitsuhiro Ito, Ryo Tominaga, Hiroshi Gomyo, Ishikazu Mizuno, Tetsuhiko Nomura, Koichi Kitagawa, Takeshi Sugimoto, Tohru Murayama, Hiroshi Matsuoka & Hironobu Minami. (2016) A prospective study of the antiemetic effect of palonosetron in malignant lymphoma patients treated with the CHOP regimen. International Journal of Hematology 104:6, pages 682-691.
Crossref
Tsutomu Takahashi, Satoshi Kumanomidou, Saki Takami, Takahiro Okada, Koji Adachi, Yumi Jo, Fumiyoshi Ikejiri, Chie Onishi, Koshi Kawakami, Takaaki Miyake, Masaya Inoue, Ichiro Moriyama, Ritsuro Suzuki & Junji Suzumiya. (2016) A retrospective study of R-CHOP/CHOP therapy-induced nausea and vomiting in non-Hodgkin’s lymphoma patients: a comparison of intravenous and oral 5-HT3 receptor antagonists. International Journal of Hematology 104:3, pages 378-383.
Crossref
Hiroyuki Takamori, Nobuko Nishiura, Hiroaki Masaie, Hitoshi Yoshida, Hironori Take, Jun Ishikawa & Takahiro Karasuno. (2016) Effectiveness of palonosetron in prevention of CHOP induced nausea and vomiting in patients with malignant lymphoma. Cancer Treatment and Research Communications 9, pages 88-91.
Crossref
Meinolf Karthaus, Csőszi Tibor, Vito Lorusso, Rajender Singh-Arora, Alexander Filippov, Giada Rizzi, Maria Elisa Borroni, Giorgia Rossi & Steven M. Grunberg. (2015) Efficacy and safety of oral palonosetron compared with IV palonosetron administered with dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with solid tumors receiving cisplatin-based highly emetogenic chemotherapy (HEC). Supportive Care in Cancer 23:10, pages 2917-2923.
Crossref